View Older Stories View More Recent Stories

Dec 9, 2020 07:40AM RA Capital Management Leads $45M Series A Financing for PepGen’s Next-Generation Oligonucleotide Platform Targeting Duchenne Muscular Dystrophy and Other Rare Neuromuscular and Cardiac Diseases
Dec 8, 2020 04:00PM Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
Dec 7, 2020 11:00AM Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics' Boltbody™ ISAC Platform
Dec 2, 2020 04:31PM Form SC 13G Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 1, 2020 08:02AM CANbridge Pharmaceuticals Completes $43 Million Series E Financing
Nov 30, 2020 02:00AM Saniona publishes its interim report for the third quarter 2020
Nov 30, 2020 02:00AM Saniona publishes its interim report for the third quarter 2020
Nov 17, 2020 12:52PM Hydrus Microstent Receives Highest Designation of Any MIGS Device as Part of AAO Treatment Guidelines
Nov 17, 2020 09:00AM Nature’s Toolbox Recruits Pharmaceutical Industry Veteran as Chief Commercial Officer 
Nov 16, 2020 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 13, 2020 08:00AM PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Nov 13, 2020 08:00AM PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Nov 12, 2020 08:13PM Adagio Medical Raises $42.5 Million In Series E Financing
Nov 10, 2020 01:18PM Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting
Nov 9, 2020 04:05PM Novavax Reports Third Quarter 2020 Financial and Operational Results
Nov 9, 2020 04:05PM Novavax Reports Third Quarter 2020 Financial and Operational Results
Nov 5, 2020 04:05PM Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
Nov 5, 2020 02:50PM Cybin Completes Reverse Take-Over Transaction
Oct 28, 2020 07:00AM Cerevel Therapeutics Debuts as Publicly Traded Neuroscience Company
Oct 22, 2020 07:30AM Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics
Oct 22, 2020 07:00AM Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines
Oct 21, 2020 10:15AM RA Capital Management, LP Closes its Second Venture Capital Fund, Raising $461 Million
Oct 14, 2020 06:00AM Nimbus Therapeutics Announces $60 Million Private Financing From New Investors to Advance Expanded Pipeline
Oct 9, 2020 04:30PM Form SC 13G Cardiff Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 7, 2020 05:00PM Form SC 13D/A Eidos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 1, 2020 09:00AM Olema Oncology Raises $85 Million in Series C Financing to Advance Clinical Development of OP-1250 in Breast Cancer
Sep 21, 2020 05:25PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 16, 2020 08:52PM Form 3 Dyne Therapeutics, Inc. For: Sep 16 Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 14, 2020 07:00AM Colorescience® Announces Successful Completion of $30 Million Debt Financing
Sep 10, 2020 04:30PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 27, 2020 02:00AM Saniona publishes its interim report for the second quarter 2020
Aug 26, 2020 09:00AM Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand
Aug 26, 2020 07:30AM Kinnate Biopharma Closes $98 Million Series C Financing
Aug 26, 2020 07:00AM Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Aug 24, 2020 08:00AM Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
Aug 18, 2020 08:30PM Form 3 Inhibrx, Inc. For: Aug 18 Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2020 04:25PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results
Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results
Aug 10, 2020 01:00AM Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares
Aug 6, 2020 09:40AM Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy
Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
Aug 5, 2020 04:30PM Form SC 13D iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 5, 2020 07:00AM GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimm
Aug 3, 2020 08:00AM PMV Pharma Closes $70 Million in Series D Financing
Jul 30, 2020 07:17AM Cerevel Therapeutics and SPAC Arya Sciences Acquisition Corp II (ARYBU) Announce Business Combination
Jul 30, 2020 07:00AM  Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development
View More Recent Stories View Older Stories